Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women

Epidemiology and Infection

Volumn 144, Issue 1, 2016, Pages 123-137

  Dareng, E O ^a,b   Ma, B ^c   Famooto, A O ^a   Akarolo Anthony, S N ^a,d   Offiong, R A ^e   Olaniyan, O ^f   Dakum, P S ^a   Wheeler, C M ^g   Fadrosh, D ^c   Yang, H ^c   Gajer, P ^c   Brotman, R M ^c   Ravel, J ^c   Adebamowo, C A ^c,d,h  

^a INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF ABUJA   (Nigeria)

^f NATIONAL HOSPITAL   (Nigeria)

^g UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^h UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

HIV AIDS; human papilloma virus (HPV); public health

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS DNA TEST; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS INERS; LEPTOTRICHIA; MAJOR CLINICAL STUDY; NIGERIAN; PAPILLOMAVIRUS INFECTION; PREVOTELLA; PROTEOBACTERIA; VAGINA FLORA; ADOLESCENT; AGED; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; NIGERIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; VAGINA; VIROLOGY; YOUNG ADULT;

BACTERIAL DNA; RNA 16S;

ADOLESCENT; ADULT; AGED; DNA, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MICROBIOTA; MIDDLE AGED; NIGERIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RNA, RIBOSOMAL, 16S; VAGINA; YOUNG ADULT;

EID: 84983127675     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815000965     Document Type: Article

References (63)

1. Ferlay J, et al. GLOBOCAN 2012 v. 1.0, Cancer incidence and mortality worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer, 2013.
2. Parkin DM, et al. Cancer in Africa 2012. Cancer Epidemiology, Biomarkers and Prevention 2014; 23: 953-966.
3. Jemal A, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology, Biomarkers and Prevention 2010; 19: 1893-1907.
4. Jedy-Agba E, et al. Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer epidemiology 2012; 36: e271-278.
5. Galloway D, et al. IARC monographs on the evaluation of carcinogenic risks to humans: human papilloma viruses, volume 90. World Health Organization, International Agency for Research on Cancer, 2007.
6. Schmeink CE, et al. Prospective follow-up of 2, 065 young unscreened women to study human papillomavirus incidence and clearance. International Journal of Cancer 2013; 133: 172-181.
7. Rodriguez AC, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. Journal of the National Cancer Institute 2010; 102: 315-324.
8. Rositch AF, et al. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Research 2012; 72: 6183-6190.
9. Clarke MA, et al. A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infectious Diseases 2012; 12: 33.
10. Herrero R, et al. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a highrisk population. Cancer 1990; 65: 380-386.
11. de Sanjose S, et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. International Journal of Cancer 1994; 56: 358-363.
12. Schmauz R, et al. Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. International Journal of Cancer 1989; 43: 805-809.
13. Gillet E, et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-Analysis. BMC Infectious Diseases 2011; 11: 10.
14. Hillier SL, et al. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstetrics and Gynecology 1992; 79: 369-373.
15. Puapermpoonsiri S, et al. Vaginal microflora associated with bacterial vaginosis in Japanese and Thai pregnant women. Clinical infectious diseases 1996; 23: 748-752.
16. Gupta K, et al. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. Journal of Infectious Diseases 1998; 178: 446-450.
17. Gray RH, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350: 1780.
18. Taha TE, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998; 12: 1699-1706.
19. Martin HL, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. Journal of Infectious Diseases 1999; 180: 1863-1868.
20. Rodriguez-Cerdeira C, Sanchez-Blanco E, Alba A. Evaluation of association between vaginal Infections and high-risk human Papillomavirus yypes in female sex workers in Spain. ISRN Obstetrics and Gynecology. Published online: 31 July 2012. doi: 10.5402/2012/240190.
21. Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annual Review of Microbiology 2012; 66: 371-389.
22. Boskey ER, et al. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infection and Immunity 1999; 67: 5170-5175.
23. Hickey RJ, et al. Understanding vaginal microbiome complexity from an ecological perspective. Translational Research 2012; 160: 267-282.
24. Spear GT, et al. Human alpha-Amylase present in lower genital gract mucosal fluid processes glycogen to support vaginal colonization by lactobacillus. Journal of Infectious Diseases 2014; 210: 1019-1028.
25. Motevaseli E, et al. Normal and tumor cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate. Journal of Medical Microbiology. Published online: 25 April 2013. doi:10.1099/jmm.0.057521-0.
26. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology 1991; 29: 297-301.
27. Amsel R, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. American Journal of Medicine 1983; 74: 14-22.
28. Castle PE, et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer epidemiology, Biomarkers and Prevention 2001; 10: 1021-1027.
29. Lee JE, et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS ONE 2013; 8: e63514.
30. Brotman RM, et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus Detection. Journal of Infectious Diseases 2014; 210: 1723-1733.
31. Borgdorff H, et al. Lactobacillus-Dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME Journal 2014; 8: 1781-1793.
32. Akarolo-Anthony SN, et al. HIV associated high-risk HPV infection among Nigerian women. BMC Infectious Diseases 2013; 13: 521.
33. Famooto A, et al. RPS19 and TYMS SNPs and prevalent high risk human papilloma virus infection in Nigerian women. PLoS ONE 2013; 8: e66930.
34. Harris PA, et al. Research electronic data capture (REDCap) - a metadata-Driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics 2009; 42: 377-381.
35. Caporaso JG, et al. Ultra-high-Throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME Journal 2012; 6: 1621-1624.
36. Masella AP, et al. PANDAseq: Paired-end assembler for illumina sequences. BMC Bioinformatics 2012; 13: 31.
37. Edgar RC, et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011; 27: 2194-2200.
38. Wang Q, et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and Environmental Microbiology 2007; 73: 5261-5267.
39. McDonald D, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME Journal 2012; 6: 610-618.
40. Stamatakis A. RAxML-VI-HPC: maximum likelihoodbased phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 2006; 22: 2688-2690.
41. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Applied and Environmental Microbiology 2005; 71: 8228-8235.
42. Caporaso JG, et al. QIIME allows analysis of highthroughput community sequencing data. Nature Methods 2010; 7: 335-336.
43. Gajer P, et al. Temporal dynamics of the human vaginal microbiota. Science Translational Medicine 2012; 4: 132ra152.
44. Oksanen J, et al. Vegan: community ecology package version 2.0-2. R CRAN package, 2011.
45. Castle PE, et al. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. Journal of Clinical Microbiology 2008; 46: 109-117.
46. Bouvard V, et al. A review of human carcinogens -Part B: biological agents. Lancet Oncology 2009; 10: 321-322.
47. Segata N, et al. Metagenomic biomarker discovery and explanation. Genome Biology 2011; 12: R60.
48. Fisher RA. The use of multiple measurements in taxonomic problems. Annals of Eugenics 1936; 7: 179-188.
49. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. Journal of the American Statistical Association 1952; 47: 583-621.
50. Cole JR, et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Research 2009; 37: D141-D145.
51. Ravel J, et al. Vaginal microbiome of reproductive-Age women. Proceedings of the National Academy of Sciences USA 2011; 108 (Suppl. 1): 4680-4687.
52. Spear GT, et al. Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. Journal of Infectious Diseases 2008; 198: 1131-1140.
53. Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annual Review of Medicine 2009; 60: 471-484.
54. Kononen E, et al. The oral gram-negative anaerobic microflora in young children: longitudinal changes from edentulous to dentate mouth. Oral Microbiology and Immunology 1994; 9: 136-141.
55. Harwich Jr. MD, et al. Genomic sequence analysis and characterization of Sneathia amnii sp. Nov. BMC Genomics 2012; 13 (Suppl. 8): S4.
56. Zhou X, et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME Journal 2007; 1: 121-133.
57. Rajamanoharan S, et al. Bacterial vaginosis, ethnicity, and the use of genital cleaning agents: a case contro study. Sexually Transmitted Diseases 1999; 26: 404-409.
58. Freedman M. Vaginal pH, estrogen and genital atrophy. Menopause Management 2008; 17: 9-13.
59. Brotman RM, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 2014; 21: 450-458.
60. Spear GT, et al. Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals Lactobacillus iners as the predominant lactobacillus species. Applied and Environmental Microbiology 2011; 77: 378-381.
61. Liu S-H, et al. Characterizing the temporal dynamics of human papillomavirus DNA detectability using shortinterval sampling. Cancer Epidemiology, Biomarkers and Prevention; 23: 200-208.
62. Hummelen R, et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS ONE 2010; 5: e12078.
63. Frank DN, et al. Altered vaginalmicrobiota are associated with perinatal mother-To-child transmission of HIV in African women from Burkina Faso. Journal of Acquired Immune Deficiency Syndromes 2012; 60: 299-306.